†<p>not statistically significant, p>0.05.</p>*<p>The number and percentage of admissions that were recorded as ‘yes’.</p
<p>Note. HR = hazard ratio. CI = confidence interval.</p><p>*p<.05.</p><p>**p <.01.</p><p>Background...
Demographic and baseline characteristics of 358 patients with hematogenous vertebral osteomyelitis.<...
Incidence rates (per 1000 PYFU) of selected most common OIs stratified by current CD4 cell count in ...
<p>Note: *USS data for 4/41 admissions in the osteomyelitis group could not be obtained, but reports...
†<p>p = 0.001, two-tailed,</p>††<p>p = 0.002, two-tailed,</p>†††<p>p = 0.046, two-tailed.</p><p>(p<0...
<p>Repeat USS findings in osteomyelitis (OM) and vaso-occlusive crisis (VOC) groups.</p
<p>The results of imaging investigations in the vaso-occlusive crisis (VOC) cohort.</p
<p>Duration of Symptoms in osteomyelitis (OM) and vaso-occlusive crisis (VOC) groups.</p
<p>Symptoms at Presentation in osteomyelitis (OM) and vaso-occlusive crisis (VOC) groups.</p
<p><i>n</i>: Number of patients found to have a co-morbid illness.</p><p><i>N</i>: Total number of A...
<p>CI: confidence interval. ns: no statistical significance (p>0.05). na: not applicable. MBD, metab...
<p>Incidence of vascular occlusive events by tertiles of predicted probability of death due to bleed...
Descriptive data on the number of women and men in the 10 largest occupational sub-major groups as w...
<p>The percentage of patients with one or more admissions during the study period is shown.</p
<p>Number of patients experiencing minor and major adverse events per study arm (related to ciclospo...
<p>Note. HR = hazard ratio. CI = confidence interval.</p><p>*p<.05.</p><p>**p <.01.</p><p>Background...
Demographic and baseline characteristics of 358 patients with hematogenous vertebral osteomyelitis.<...
Incidence rates (per 1000 PYFU) of selected most common OIs stratified by current CD4 cell count in ...
<p>Note: *USS data for 4/41 admissions in the osteomyelitis group could not be obtained, but reports...
†<p>p = 0.001, two-tailed,</p>††<p>p = 0.002, two-tailed,</p>†††<p>p = 0.046, two-tailed.</p><p>(p<0...
<p>Repeat USS findings in osteomyelitis (OM) and vaso-occlusive crisis (VOC) groups.</p
<p>The results of imaging investigations in the vaso-occlusive crisis (VOC) cohort.</p
<p>Duration of Symptoms in osteomyelitis (OM) and vaso-occlusive crisis (VOC) groups.</p
<p>Symptoms at Presentation in osteomyelitis (OM) and vaso-occlusive crisis (VOC) groups.</p
<p><i>n</i>: Number of patients found to have a co-morbid illness.</p><p><i>N</i>: Total number of A...
<p>CI: confidence interval. ns: no statistical significance (p>0.05). na: not applicable. MBD, metab...
<p>Incidence of vascular occlusive events by tertiles of predicted probability of death due to bleed...
Descriptive data on the number of women and men in the 10 largest occupational sub-major groups as w...
<p>The percentage of patients with one or more admissions during the study period is shown.</p
<p>Number of patients experiencing minor and major adverse events per study arm (related to ciclospo...
<p>Note. HR = hazard ratio. CI = confidence interval.</p><p>*p<.05.</p><p>**p <.01.</p><p>Background...
Demographic and baseline characteristics of 358 patients with hematogenous vertebral osteomyelitis.<...
Incidence rates (per 1000 PYFU) of selected most common OIs stratified by current CD4 cell count in ...
DOI
Add to ORKG